Literature DB >> 2622863

Macromolecular prodrugs. XVI. Colon-targeted delivery--comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal (GI) tract.

C Larsen1, E Harboe, M Johansen, H P Olesen.   

Abstract

We have determined initial rates of naproxen formation from dextran-naproxen ester prodrugs incubated in homogenates of various segments of the pig GI tract. Drug liberation proceeded 15-17 times faster in cecum and colon homogenates than in aqueous pH 7.4 buffer or homogenates of the small intestine. The degree of conjugate substitution did not affect the liberation rates, whereas enhanced drug activation was observed with decreasing molecular size of the carrier dextran. During incubation in colon homogenates the average molecular weight of the dextran prodrugs decreased. The mechanism of drug activation from the prodrugs may therefore involve an initial depolymerization step of the dextran chains by dextranases secreted from bacteria in the pig colon. The generated small fragments then serve as substrates for esterases and other hydrolases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2622863     DOI: 10.1023/a:1015914101233

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  OBSERVATIONS ON THE FLORA OF THE ALIMENTARY TRACT OF ANIMALS AND FACTORS AFFECTING ITS COMPOSITION.

Authors:  H W SMITH
Journal:  J Pathol Bacteriol       Date:  1965-01

Review 2.  Metabolism of foreign compounds by gastrointestinal microorganisms.

Authors:  R R Scheline
Journal:  Pharmacol Rev       Date:  1973-12       Impact factor: 25.468

3.  The synthesis of cross-linked dextran and its enzymatic hydrolysis.

Authors:  M Ceska
Journal:  Experientia       Date:  1971

4.  Characterization of dextran glucosidase (1,6-a-D-glucan glucohydrolase) of Streptococcus mitis.

Authors:  L Linder; M L Sund
Journal:  Caries Res       Date:  1981       Impact factor: 4.056

5.  Metabolism of orally administered dextran and 'Sephadex' derivatives in the rat.

Authors:  T M Parkinson
Journal:  Nature       Date:  1967-07-22       Impact factor: 49.962

6.  Intracellular glycosidases of human colon Bacteroides ovatus B4-11.

Authors:  N R Reddy; J K Palmer; M D Pierson; R J Bothast
Journal:  Appl Environ Microbiol       Date:  1984-10       Impact factor: 4.792

7.  Macromolecular prodrugs. XV. Colon-targeted delivery--bioavailability of naproxen from orally administered dextran-naproxen ester prodrugs varying in molecular size in the pig.

Authors:  E Harboe; C Larsen; M Johansen; H P Olesen
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

8.  Degradation of polysaccharides by endo- and exoenzymes: dextran-dextranase model systems.

Authors:  M A Wheatley; M Moo-Young
Journal:  Biotechnol Bioeng       Date:  1977-02       Impact factor: 4.530

  8 in total
  8 in total

Review 1.  ["Targeted delivery" in the gastrointestinal tract].

Authors:  C S Leopold
Journal:  Med Klin (Munich)       Date:  1999-02-15

2.  Pharmacokinetic modeling of absorption behavior of 9-aminocamptothecin (9-AC) released from colon-specific HPMA copolymer-9-AC conjugate in rats.

Authors:  Song-Qi Gao; Yongen Sun; Pavla Kopecková; C Matthew Peterson; Jindrich Kopecek
Journal:  Pharm Res       Date:  2007-10-11       Impact factor: 4.200

3.  In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier.

Authors:  A Rubinstein; R Radai; M Ezra; S Pathak; J S Rokem
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

4.  Multiple oral administration of a ketoprofen-dextran ester prodrug in pigs: assessment of gastrointestinal bioavailability by deconvolution.

Authors:  F Larsen; B H Jensen; H P Olesen; C Larsen
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

5.  A novel protocol allowing oral delivery of a protein complement inhibitor that subsequently targets to inflamed colon mucosa and ameliorates murine colitis.

Authors:  M Elvington; P Blichmann; F Qiao; M Scheiber; C Wadsworth; I Luzinov; J Lucero; A Vertegel; S Tomlinson
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

6.  In vitro evaluation of poly(caporlactone) grafted dextran (PGD) nanoparticles with cancer cell.

Authors:  P Prabu; Atul A Chaudhari; Santosh Aryal; N Dharmaraj; S Y Park; W D Kim; H Y Kim
Journal:  J Mater Sci Mater Med       Date:  2007-11-28       Impact factor: 3.896

7.  Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes.

Authors:  Wooseong Kim; Yejin Yang; Dohoon Kim; Seongkeun Jeong; Jin-Wook Yoo; Jeong-Hyun Yoon; Yunjin Jung
Journal:  Drug Des Devel Ther       Date:  2017-02-14       Impact factor: 4.162

8.  Dextran Carrier Macromolecules for Colon-specific Delivery of 5-Aminosalicylic Acid.

Authors:  P K Shrivastava; A Shrivastava; S K Sinha; S K Shrivastava
Journal:  Indian J Pharm Sci       Date:  2013-05       Impact factor: 0.975

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.